Calmodulin kinase II inhibition disrupts cardiomyopathic effects of enhanced green fluorescent protein

Journal of Molecular and Cellular Cardiology

Volumn 44, Issue 2, 2008, Pages 405-410

  Khoo, Michelle S C ^a   Grueter, Chad E ^b,c   Eren, Mesut ^b   Yang, Jinying ^d   Zhang, Rong ^b   Bass, Martha A ^c   Lwin, Seint T ^b   Mendes, Lisa A ^b   Vaughan, Douglas E ^b   Colbran, Roger J ^c   Anderson, Mark E ^d  

^a UNIVERSITY OF COLORADO   (United States)

^b VANDERBILT UNIVERSITY   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF IOWA   (United States)

Author keywords

Calmodulin kinase II; Cardiomyopathy; eGFP

Indexed keywords

GREEN FLUORESCENT PROTEIN; PROTEIN KINASE (CALCIUM,CALMODULIN) II;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOMYOPATHY; CONTROLLED STUDY; ENZYME ACTIVITY; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; MOUSE; NONHUMAN; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; CARDIOMYOPATHIES; GREEN FLUORESCENT PROTEINS; HEART VENTRICLES; HYPERTROPHY; MICE; MICE, TRANSGENIC; ORGAN SIZE; PEPTIDES; VENTRICULAR FUNCTION, LEFT;

ANIMALIA;

EID: 38949097498     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2007.10.014     Document Type: Article

References (18)

1. Huang W., Aramburu J., Douglas P.S., and Izumo S. Transgenic expression of green fluorescence protein can cause dilated cardiomyopathy. Nat Med 6 (2000) 482-483
2. 2+/calmodulin-dependent protein kinase II in cardiac hypertrophy and heart failure. Cardiovasc Res 63 (2004) 476-486
3. Zhang R., Khoo M.S., Wu Y., Yang Y., Grueter C.E., Ni G., et al. Calmodulin kinase II inhibition protects against structural heart disease. Nat Med 11 (2005) 409-417
4. + channel by calmodulin-binding peptides. J Physiol (London) 527 (2000) 479-492
5. Rottman J.N., Ni G., Khoo M., Wang Z., Zhang W., Anderson M.E., et al. Temporal changes in ventricular function assessed echocardiographically in conscious and anesthetized mice. J Am Soc Echocardiogr 16 (2003) 1150-1157
6. Wu Y., Temple J., Zhang R., Dzhura I., Zhang W., Trimble R.W., et al. Calmodulin kinase II and arrhythmias in a mouse model of cardiac hypertrophy. Circulation 106 (2002) 1288-1293
7. Zhang T., Maier L.S., Dalton N.D., Miyamoto S., Ross Jr. J., Bers D.M., et al. The deltaC isoform of CaMKII is activated in cardiac hypertrophy and induces dilated cardiomyopathy and heart failure. Circ Res 92 (2003) 912-919
8. Molkentin J.D., Lu J.R., Antos C.L., Markham B., Richardson J., Robbins J., et al. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 93 (1998) 215-228
9. Khoo M.S., Li J., Singh M.V., Yang Y., Kannankeril P., Wu Y., et al. Death, cardiac dysfunction, and arrhythmias are increased by calmodulin kinase II in calcineurin cardiomyopathy. Circulation 114 (2006) 1352-1359
10. Ellis R.J. Macromolecular crowding: an important but neglected aspect of the intracellular environment. Curr Opin Struct Biol 11 (2001) 114-119
11. Martin J., and Hartl F.U. The effect of macromolecular crowding on chaperonin-mediated protein folding. Proc Natl Acad Sci U S A 94 (1997) 1107-1112
12. Rosenzweig M., Connole M., Glickman R., Yue S.P., Noren B., DeMaria M., et al. Induction of cytotoxic T lymphocyte and antibody responses to enhanced green fluorescent protein following transplantation of transduced CD34(+) hematopoietic cells. Blood 97 (2001) 1951-1959
13. Stripecke R., Carmen V.M., Skelton D., Satake N., Halene S., and Kohn D. Immune response to green fluorescent protein: implications for gene therapy. Gene Ther 6 (1999) 1305-1312
14. McCloskey D.T., Turnbull L., Swigart P.M., Zambon A.C., Turcato S., Joho S., et al. Cardiac transgenesis with the tetracycline transactivator changes myocardial function and gene expression. Physiol Genomics 22 (2005) 118-126
15. Nyqvist D., Mattsson G., Kohler M., Lev-Ram V., Andersson A., Carlsson P.O., et al. Pancreatic islet function in a transgenic mouse expressing fluorescent protein. J Endocrinol 186 (2005) 333-341
16. Sekar R.B., Kizana E., Smith R.R., Barth A.S., Zhang Y., Marban E., et al. Lentiviral vector mediated expression of GFP or Kir2.1 alters the 296 electrophysiology of neonatal rat ventricular myocytes without inducing 297 cytotoxicity. Am J Physiol Heart Circ Physiol 293(5) (2007 (Aug. 3)) H2757-70 Electronic publication ahead of print
17. Kizana E., Chang C.Y., Cingolani E., Ramirez-Correa G.A., Sekar R.B., Abraham M.R., et al. Gene transfer of connexin43 mutants attenuates coupling in cardiomyocytes: novel basis for modulation of cardiac conduction by gene therapy. Circ Res 100 (2007) 1597-1604
18. Lopatin A.N., Makhina E.N., and Nichols C.G. Novel tools for localizing ion channels in living cells. Trends Pharmacol Sci 19 (1998) 395-408